TY - JOUR AU - Defronzo, R. A. PY - 2009 DA - 2009// TI - Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus JO - Diabetes. VL - 58 UR - https://doi.org/10.2337/db09-9028 DO - 10.2337/db09-9028 ID - Defronzo2009 ER - TY - JOUR AU - Pratley, R. E. AU - Weyer, C. PY - 2002 DA - 2002// TI - Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion JO - Curr Diab Rep. VL - 2 UR - https://doi.org/10.1007/s11892-002-0090-6 DO - 10.1007/s11892-002-0090-6 ID - Pratley2002 ER - TY - JOUR AU - Knop, F. K. AU - Aaboe, K. AU - Vilsbøll, T. AU - Vølund, A. AU - Holst, J. J. AU - Krarup, T. PY - 2012 DA - 2012// TI - Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity JO - Diabetes Obes Metab VL - 14 UR - https://doi.org/10.1111/j.1463-1326.2011.01549.x DO - 10.1111/j.1463-1326.2011.01549.x ID - Knop2012 ER - TY - JOUR AU - Baron, A. D. AU - Schaeffer, L. AU - Shragg, P. AU - Kolterman, O. G. PY - 1987 DA - 1987// TI - Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics JO - Diabetes VL - 36 UR - https://doi.org/10.2337/diab.36.3.274 DO - 10.2337/diab.36.3.274 ID - Baron1987 ER - TY - JOUR AU - Matsuda, M. AU - Defronzo, R. A. AU - Glass, L. AU - Consoli, A. AU - Giordano, M. AU - Bressler, P. PY - 2002 DA - 2002// TI - Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals JO - Metabolism. VL - 51 UR - https://doi.org/10.1053/meta.2002.34700 DO - 10.1053/meta.2002.34700 ID - Matsuda2002 ER - TY - JOUR AU - Boden, G. PY - 2002 DA - 2002// TI - Interaction between free fatty acids and glucose metabolism JO - Curr Opin Clin Nutr Metab Care. VL - 5 UR - https://doi.org/10.1097/00075197-200209000-00014 DO - 10.1097/00075197-200209000-00014 ID - Boden2002 ER - TY - JOUR AU - Inzucchi, S. E. AU - Bergenstal, R. M. AU - Buse, J. B. AU - Diamant, M. AU - Ferrannini, E. AU - Nauck, M. PY - 2012 DA - 2012// TI - Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) JO - Diabetes Care VL - 35 UR - https://doi.org/10.2337/dc12-0413 DO - 10.2337/dc12-0413 ID - Inzucchi2012 ER - TY - JOUR AU - Maruthur, N. M. AU - Tseng, E. AU - Hutfless, S. AU - Wilson, L. M. AU - Suarez-Cuervo, C. AU - Berger, Z. PY - 2016 DA - 2016// TI - Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis JO - Ann Intern Med VL - 164 UR - https://doi.org/10.7326/M15-2650 DO - 10.7326/M15-2650 ID - Maruthur2016 ER - TY - JOUR AU - Vitale, C. AU - Mercuro, G. AU - Cornoldi, A. AU - Fini, M. AU - Volterrani, M. AU - Rosano, G. M. C. PY - 2005 DA - 2005// TI - Metformin improves endothelial function in patients with metabolic syndrome JO - J Intern Med. VL - 258 UR - https://doi.org/10.1111/j.1365-2796.2005.01531.x DO - 10.1111/j.1365-2796.2005.01531.x ID - Vitale2005 ER - TY - JOUR AU - Sun, W. AU - Zeng, C. AU - Liao, L. AU - Chen, J. AU - Wang, Y. PY - 2016 DA - 2016// TI - Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obese JO - Curr Med Res Opin VL - 32 UR - https://doi.org/10.1080/03007995.2016.1176013 DO - 10.1080/03007995.2016.1176013 ID - Sun2016 ER - TY - JOUR AU - Holst, J. J. PY - 1994 DA - 1994// TI - Glucagonlike peptide 1: a newly discovered gastrointestinal hormone JO - Gastroenterology VL - 107 UR - https://doi.org/10.1016/0016-5085(94)90831-1 DO - 10.1016/0016-5085(94)90831-1 ID - Holst1994 ER - TY - JOUR AU - Meier, J. J. PY - 2012 DA - 2012// TI - GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus JO - Nat Rev Endocrinol. VL - 8 UR - https://doi.org/10.1038/nrendo.2012.140 DO - 10.1038/nrendo.2012.140 ID - Meier2012 ER - TY - JOUR AU - Vilsbøll, T. AU - Christensen, M. AU - Junker, A. E. AU - Knop, F. K. AU - Gluud, L. L. PY - 2012 DA - 2012// TI - Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials JO - BMJ VL - 344 UR - https://doi.org/10.1136/bmj.d7771 DO - 10.1136/bmj.d7771 ID - Vilsbøll2012 ER - TY - JOUR AU - Madsbad, S. AU - Schmitz, O. AU - Ranstam, J. AU - Jakobsen, G. AU - Matthews, D. R. PY - 2004 DA - 2004// TI - Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial JO - Diabetes Care. VL - 27 UR - https://doi.org/10.2337/diacare.27.6.1335 DO - 10.2337/diacare.27.6.1335 ID - Madsbad2004 ER - TY - JOUR AU - Zinman, B. AU - Gerich, J. AU - Buse, J. B. AU - Lewin, A. AU - Schwartz, S. AU - Raskin, P. PY - 2009 DA - 2009// TI - Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc08-2124 DO - 10.2337/dc08-2124 ID - Zinman2009 ER - TY - JOUR AU - Marre, M. AU - Shaw, J. AU - Brändle, M. AU - Bebakar, W. M. W. AU - Kamaruddin, N. A. AU - Strand, J. PY - 2009 DA - 2009// TI - Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU) JO - Diabet Med. VL - 26 UR - https://doi.org/10.1111/j.1464-5491.2009.02666.x DO - 10.1111/j.1464-5491.2009.02666.x ID - Marre2009 ER - TY - JOUR AU - Garber, A. AU - Henry, R. AU - Ratner, R. AU - Garcia-Hernandez, P. A. AU - Rodriguez-Pattzi, H. AU - Olvera-Alvarez, I. PY - 2009 DA - 2009// TI - Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial JO - Lancet. VL - 373 UR - https://doi.org/10.1016/S0140-6736(08)61246-5 DO - 10.1016/S0140-6736(08)61246-5 ID - Garber2009 ER - TY - JOUR AU - Buse, J. B. AU - Rosenstock, J. AU - Sesti, G. AU - Schmidt, W. E. AU - Montanya, E. AU - Brett, J. H. PY - 2009 DA - 2009// TI - Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60659-0 DO - 10.1016/S0140-6736(09)60659-0 ID - Buse2009 ER - TY - JOUR AU - Nauck, M. AU - Frid, A. AU - Hermansen, K. AU - Shah, N. S. AU - Tankova, T. AU - Mitha, I. H. PY - 2009 DA - 2009// TI - Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study JO - Diabetes Care VL - 32 UR - https://doi.org/10.2337/dc08-1355 DO - 10.2337/dc08-1355 ID - Nauck2009 ER - TY - JOUR AU - Zander, M. AU - Madsbad, S. AU - Madsen, J. L. AU - Holst, J. J. PY - 2002 DA - 2002// TI - Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)07952-7 DO - 10.1016/S0140-6736(02)07952-7 ID - Zander2002 ER - TY - JOUR AU - Vilsbøll, T. AU - Brock, B. AU - Perrild, H. AU - Levin, K. AU - Lervang, H. -. H. AU - Kølendorf, K. PY - 2008 DA - 2008// TI - Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus JO - Diabet Med VL - 25 UR - https://doi.org/10.1111/j.1464-5491.2007.02333.x DO - 10.1111/j.1464-5491.2007.02333.x ID - Vilsbøll2008 ER - TY - JOUR AU - Jinnouchi, H. AU - Sugiyama, S. AU - Yoshida, A. AU - Hieshima, K. AU - Kurinami, N. AU - Suzuki, T. PY - 2015 DA - 2015// TI - Liraglutide, a glucagon-like peptide-1 analog, increased insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp examination in patients with uncontrolled type 2 diabetes mellitus JO - J Diabetes Res. VL - 2015 UR - https://doi.org/10.1155/2015/706416 DO - 10.1155/2015/706416 ID - Jinnouchi2015 ER - TY - JOUR AU - Kim, S. H. AU - Liu, A. AU - Ariel, D. AU - Abbasi, F. AU - Lamendola, C. AU - Grove, K. PY - 2014 DA - 2014// TI - Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study JO - Diabetologia. VL - 57 UR - https://doi.org/10.1007/s00125-013-3134-3 DO - 10.1007/s00125-013-3134-3 ID - Kim2014 ER - TY - JOUR AU - Pararajasingam, G. AU - Høfsten, D. E. AU - Løgstrup, B. B. AU - Egstrup, M. AU - Henriksen, F. L. AU - Hangaard, J. PY - 2016 DA - 2016// TI - Newly detected abnormal glucose regulation and long-term prognosis after acute myocardial infarction: comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c JO - Int J Cardiol VL - 214 UR - https://doi.org/10.1016/j.ijcard.2016.03.199 DO - 10.1016/j.ijcard.2016.03.199 ID - Pararajasingam2016 ER - TY - JOUR AU - Cheng, A. Y. Y. AU - Lau, D. C. W. PY - 2013 DA - 2013// TI - The Canadian Diabetes Association 2013 clinical practice guidelines-raising the bar and setting higher standards! JO - Can J Diabetes. VL - 37 UR - https://doi.org/10.1016/j.jcjd.2013.04.005 DO - 10.1016/j.jcjd.2013.04.005 ID - Cheng2013 ER - TY - JOUR AU - Diabetes, D. O. F. PY - 2013 DA - 2013// TI - Diagnosis and classification of diabetes mellitus JO - Diabetes Care VL - 36 ID - Diabetes2013 ER - TY - JOUR AU - Anholm, C. AU - Kumarathurai, P. AU - Klit, M. S. AU - Kristiansen, O. P. AU - Nielsen, O. W. AU - Ladelund, S. PY - 2014 DA - 2014// TI - Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol JO - BMJ Open VL - 4 UR - https://doi.org/10.1136/bmjopen-2014-005942 DO - 10.1136/bmjopen-2014-005942 ID - Anholm2014 ER - TY - JOUR AU - Holst, J. J. PY - 1982 DA - 1982// TI - Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33–69) of glicentin JO - Biochem J. VL - 207 UR - https://doi.org/10.1042/bj2070381 DO - 10.1042/bj2070381 ID - Holst1982 ER - TY - JOUR AU - Albrechtsen, N. J. W. AU - Hartmann, B. AU - Veedfald, S. AU - Idorn, T. AU - Feldt-rasmussen, B. AU - Knop, F. K. PY - 2014 DA - 2014// TI - Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? JO - Diabetologia VL - 57 UR - https://doi.org/10.1007/s00125-014-3283-z DO - 10.1007/s00125-014-3283-z ID - Albrechtsen2014 ER - TY - JOUR AU - Matsuda, M. AU - DeFronzo, R. A. PY - 1999 DA - 1999// TI - Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp JO - Diabetes Care VL - 22 UR - https://doi.org/10.2337/diacare.22.9.1462 DO - 10.2337/diacare.22.9.1462 ID - Matsuda1999 ER - TY - JOUR AU - Matthews, D. R. AU - Hosker, J. R. AU - Rudenski, A. S. AU - Naylor, B. A. AU - Treacher, D. F. AU - Turner, R. C. PY - 1985 DA - 1985// TI - Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man JO - Diabetologia VL - 28 UR - https://doi.org/10.1007/BF00280883 DO - 10.1007/BF00280883 ID - Matthews1985 ER - TY - JOUR AU - Hovorka, R. AU - Soons, P. A. AU - Young, M. A. PY - 1996 DA - 1996// TI - ISEC: a program to calculate insulin secretion JO - Comput Methods Programs Biomed VL - 50 UR - https://doi.org/10.1016/0169-2607(96)01755-5 DO - 10.1016/0169-2607(96)01755-5 ID - Hovorka1996 ER - TY - JOUR AU - Bergman, R. N. AU - Ader, M. AU - Huecking, K. AU - Citters, G. PY - 2002 DA - 2002// TI - Accurate Assessment of beta-cell function—the hyperbolic correction JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.2007.S212 DO - 10.2337/diabetes.51.2007.S212 ID - Bergman2002 ER - TY - JOUR AU - Allison, D. B. AU - Paultre, F. AU - Maggio, C. AU - Mezzitis, N. AU - Pi-Sunyer, F. X. PY - 1995 DA - 1995// TI - The use of areas under curves in diabetes research JO - Diabetes Care VL - 18 UR - https://doi.org/10.2337/diacare.18.2.245 DO - 10.2337/diacare.18.2.245 ID - Allison1995 ER - TY - JOUR AU - Polonsky, K. S. AU - Given, B. D. AU - Hirsch, L. AU - Shapiro, E. T. AU - Tillil, H. AU - Beebe, C. PY - 1988 DA - 1988// TI - Quantitative study of insulin secretion and clearance in normal and obese subjects JO - J Clin Invest. VL - 81 UR - https://doi.org/10.1172/JCI113338 DO - 10.1172/JCI113338 ID - Polonsky1988 ER - TY - JOUR AU - Haugaard, S. B. AU - Andersen, O. AU - Vølund, A. AU - Hansen, B. R. AU - Iversen, J. AU - Andersen, U. B. PY - 2005 DA - 2005// TI - Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy JO - Clin Endocrinol VL - 62 UR - https://doi.org/10.1111/j.1365-2265.2005.02223.x DO - 10.1111/j.1365-2265.2005.02223.x ID - Haugaard2005 ER - TY - JOUR AU - Kahn, S. E. AU - Prigeon, R. L. AU - McCulloch, D. K. AU - Boyko, E. J. AU - Bergman, R. N. AU - Schwartz, M. W. PY - 1993 DA - 1993// TI - Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function JO - Diabetes. VL - 42 UR - https://doi.org/10.2337/diab.42.11.1663 DO - 10.2337/diab.42.11.1663 ID - Kahn1993 ER - TY - JOUR AU - Campioni, M. AU - Toffolo, G. AU - Basu, R. AU - Rizza, R. A. AU - Cobelli, C. PY - 2009 DA - 2009// TI - Minimal model assessment of hepatic insulin extraction during an oral test from standard insulin kinetic parameters JO - Am J Physiol Endocrinol Metab. VL - 297 UR - https://doi.org/10.1152/ajpendo.90842.2008 DO - 10.1152/ajpendo.90842.2008 ID - Campioni2009 ER - TY - JOUR AU - Anholm, C. AU - Kumarathurai, P. AU - Pedersen, L. R. AU - Nielsen, O. W. AU - Kristiansen, O. P. AU - Fenger, M. PY - 2017 DA - 2017// TI - Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes JO - Diabetes Obes Metab VL - 19 UR - https://doi.org/10.1111/dom.12891 DO - 10.1111/dom.12891 ID - Anholm2017 ER - TY - BOOK AU - Senn, S. PY - 2002 DA - 2002// TI - Cross-over trials in clinical research PB - Wiley CY - Chichester UR - https://doi.org/10.1002/0470854596 DO - 10.1002/0470854596 ID - Senn2002 ER - TY - JOUR AU - Kumarathurai, P. AU - Anholm, C. AU - Nielsen, O. W. AU - Kristiansen, O. P. AU - Mølvig, J. AU - Madsbad, S. PY - 2016 DA - 2016// TI - Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study JO - Cardiovasc Diabetol. VL - 15 UR - https://doi.org/10.1186/s12933-016-0425-2 DO - 10.1186/s12933-016-0425-2 ID - Kumarathurai2016 ER - TY - JOUR AU - Bonora, E. AU - Zavaroni, I. AU - Coscelli, C. AU - Butturini, U. PY - 1983 DA - 1983// TI - Decreased hepatic insulin extraction in subjects with mild glucose intolerance JO - Metabolism. VL - 32 UR - https://doi.org/10.1016/0026-0495(83)90004-5 DO - 10.1016/0026-0495(83)90004-5 ID - Bonora1983 ER - TY - JOUR AU - Viljanen, A. P. M. AU - Iozzo, P. AU - Borra, R. AU - Kankaanpää, M. AU - Karmi, A. AU - Lautamäki, R. PY - 2009 DA - 2009// TI - Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance JO - J Clin Endocrinol Metab VL - 94 UR - https://doi.org/10.1210/jc.2008-1689 DO - 10.1210/jc.2008-1689 ID - Viljanen2009 ER - TY - JOUR AU - Tanaka, K. AU - Saisho, Y. AU - Manesso, E. AU - Tanaka, M. AU - Meguro, S. AU - Irie, J. PY - 2015 DA - 2015// TI - Effects of liraglutide monotherapy on beta cell function and pancreatic enzymes compared with metformin in japanese overweight/obese patients with type 2 diabetes mellitus: a subpopulation analysis of the KIND-LM randomized trial JO - Clin Drug Investig. VL - 35 UR - https://doi.org/10.1007/s40261-015-0331-5 DO - 10.1007/s40261-015-0331-5 ID - Tanaka2015 ER - TY - JOUR AU - Juhl, C. B. AU - Hollingdal, M. AU - Sturis, J. AU - Jakobsen, G. AU - Agersø, H. AU - Veldhuis, J. PY - 2002 DA - 2002// TI - Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes JO - Diabetes VL - 51 UR - https://doi.org/10.2337/diabetes.51.2.424 DO - 10.2337/diabetes.51.2.424 ID - Juhl2002 ER - TY - JOUR AU - Nauck, M. A. AU - Kleine, N. AU - Orskov, C. AU - Holst, J. J. AU - Willms, B. AU - Creutzfeldt, W. PY - 1993 DA - 1993// TI - Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7–36 amide) in type 2 (non-insulin-dependent) diabetic patients JO - Diabetologia VL - 36 UR - https://doi.org/10.1007/BF00401145 DO - 10.1007/BF00401145 ID - Nauck1993 ER - TY - JOUR AU - Kramer, C. K. AU - Zinman, B. AU - Choi, H. AU - Connelly, P. W. AU - Retnakaran, R. PY - 2015 DA - 2015// TI - The impact of chronic liraglutide therapy on glucagon secretion in type 2 diabetes: insight From the LIBRA trial JO - J Clin Endocrinol Metab VL - 100 UR - https://doi.org/10.1210/jc.2015-2725 DO - 10.1210/jc.2015-2725 ID - Kramer2015 ER - TY - JOUR AU - Kramer, C. K. AU - Zinman, B. AU - Choi, H. AU - Connelly, P. W. AU - Retnakaran, R. PY - 2017 DA - 2017// TI - Impact of the glucagon assay when assessing the effect of chronic liraglutide therapy on glucagon secretion JO - J Clin Endocrinol Metab. VL - 102 UR - https://doi.org/10.1210/jc.2017-00928 DO - 10.1210/jc.2017-00928 ID - Kramer2017 ER - TY - JOUR AU - Dandona, P. AU - Ghanim, H. AU - Abuaysheh, S. AU - Green, K. AU - Batra, M. AU - Dhindsa, S. PY - 2015 DA - 2015// TI - Decreased insulin secretion and incretin concentrations and increased glucagon concentrations after a high-fat meal when compared with a high-fruit and -fiber meal JO - Am J Physiol Endocrinol Metab VL - 308 UR - https://doi.org/10.1152/ajpendo.00275.2014 DO - 10.1152/ajpendo.00275.2014 ID - Dandona2015 ER - TY - JOUR AU - Alsalim, W. AU - Tura, A. AU - Pacini, G. AU - Omar, B. AU - Bizzotto, R. AU - Mari, A. PY - 2016 DA - 2016// TI - Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes JO - Diabetes Obes Metab VL - 18 UR - https://doi.org/10.1111/dom.12570 DO - 10.1111/dom.12570 ID - Alsalim2016 ER - TY - JOUR AU - Boston, R. C. AU - Moate, P. J. PY - 2008 DA - 2008// TI - NEFA minimal model parameters estimated from the oral glucose tolerance test and the meal tolerance test JO - Am J Physiol Regul Integr Comp Physiol VL - 295 UR - https://doi.org/10.1152/ajpregu.90317.2008 DO - 10.1152/ajpregu.90317.2008 ID - Boston2008 ER - TY - JOUR AU - Ostawal, A. AU - Mocevic, E. AU - Kragh, N. AU - Xu, W. PY - 2016 DA - 2016// TI - Clinical Effectiveness of liraglutide in type 2 diabetes treatment in the real-world setting: a systematic literature review JO - Diabetes Ther. VL - 7 UR - https://doi.org/10.1007/s13300-016-0180-0 DO - 10.1007/s13300-016-0180-0 ID - Ostawal2016 ER - TY - JOUR AU - Marso, S. P. AU - Daniels, G. H. AU - Brown-Frandsen, K. AU - Kristensen, P. AU - Mann, J. F. E. AU - Nauck, M. A. PY - 2016 DA - 2016// TI - Liraglutide and cardiovascular outcomes in type 2 diabetes JO - N Engl J Med. VL - 375 UR - https://doi.org/10.1056/NEJMoa1603827 DO - 10.1056/NEJMoa1603827 ID - Marso2016 ER - TY - JOUR AU - Blonde, L. AU - Russell-Jones, D. PY - 2009 DA - 2009// TI - The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies JO - Diabetes Obes Metab VL - 11 UR - https://doi.org/10.1111/j.1463-1326.2009.01075.x DO - 10.1111/j.1463-1326.2009.01075.x ID - Blonde2009 ER - TY - STD TI - Funch D, Mortimer K, Ziyadeh NJ, Seeger JD, Li L, Norman H, et al. Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population. Diabetes Obes Metab. 2019; (Epub ahead). ID - ref55 ER -